Cover Image
市場調查報告書

行動醫療的全球市場預測 對2015-2022年:生態系統 (設備 & 服務) 、治療、應用/解決方案類型、地區的關注

Global Mobile Health (mHealth) Market: Focus on Ecosystem (Devices & Services), Therapeutics, Application/Solution Type & Regions - Estimation & Forecast 2015 to 2022

出版商 BIS Research 商品編碼 337698
出版日期 內容資訊 英文 303 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
行動醫療的全球市場預測 對2015-2022年:生態系統 (設備 & 服務) 、治療、應用/解決方案類型、地區的關注 Global Mobile Health (mHealth) Market: Focus on Ecosystem (Devices & Services), Therapeutics, Application/Solution Type & Regions - Estimation & Forecast 2015 to 2022
出版日期: 2015年08月20日 內容資訊: 英文 303 Pages
簡介

行動醫療是醫療產業上最現代化的趨勢之一,這數年來實現驚異性的進步。行動醫療的服務市場區隔獨佔2014年的市場,由於醫療提供者,製藥企業及終端用戶 (患者) 對行動醫療解決方案的利用擴大,預計到預測期間末超過556億3,000萬美元。行動醫療的設備市場區隔,由行動醫療設備和智慧型手機的整合擴大,及連線健診解決方案的機會增加,在預測期間促進該市場的成長,預計從2015年到2022年以38.02%的年複合成長率擴大。

本報告提供全球行動醫療市場相關調查、市場概要、生態系統、各治療領域、各應用/解決方案類型、各地區的市場分析與預測、發展策略,及主要企業簡介等彙整,為您概述為以下內容。

第1章 調查範圍

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 市場動態
    • 市場成長的促進要素
    • 市場課題
    • 市場機會

第4章 產業動態

  • 行動醫療市場時間軸
  • 行動醫療市場價值鏈
    • 設備廠商
    • 規格
    • 行動醫療設備:波特的五力分析
    • 買主談判力
    • 賣主談判力
    • 替代品的威脅
    • 新加入者的威脅
    • 產業內敵對關係的強度

第5章 全球行動醫療市場生態系統

  • 簡介
    • 行動醫療設備
    • 醫療設備
      • SMBG螢幕
      • 血壓 (BP) 螢幕
      • 心臟監測
      • 主要企業
      • 其他醫療設備
      • 其他的設備
    • 行動醫療應用、內容解決方案
    • 網路及服務/手機業者
    • 醫療及醫藥品

第6章 全球行動醫療市場:治療

  • 簡介
    • 全球市場的統計
    • 設備
    • 應用
    • 主要企業
  • 糖尿病
    • 設備
    • 應用
    • 主要企業
  • 呼吸
  • 精神、神經疾病
  • 健身、生活方式治療

第7章 全球行動醫療市場:應用/解決方案類型

  • 簡介
    • 監測
    • 診斷、治療
    • 教育、認識
    • 醫療經營管理
    • 健康、預防
    • 其他/其他服務、應用市場
    • 遠程資料收集

第8章 全球行動醫療市場:各地區

  • 簡介
    • 市場統計
    • 南北美洲
    • 北美
    • 亞太地區 (APAC)
    • 歐洲
    • 其他 (ROW)
    • 中東

第9章 主要市場發展趨勢及策略

  • 簡介

第10章 企業簡介

  • AGAMATRIX, INC.
    • 概要
    • 財務
    • 主要的發展趨勢
  • ALIVECOR, INC.
  • APPLE, INC.
  • ATHENAHEALTH INC.
  • AT&T, INC.
  • BIOTELEMETRY, INC. (CARDIONET)
  • GE HEALTHCARE
  • GOOGLE INC.
  • JAWBONE, INC.
  • JOHNSON & JOHNSON
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • MEDTRONIC PLC
  • NIKE INC.
  • PFIZER
  • PHILIPS HEALTHCARE
  • QUALCOMM, INC.
  • QUEST DIAGNOSTICS INC.
  • ROCHE HOLDING AG-BR
  • SAMSUNG ELECTRONICS CO. LTD.
  • SANOFI PHARMA
  • WITHINGS SAS

圖表

目錄
Product Code: MD04

Mobile health (mHealth) is one of the most modernized trends in the healthcare industry that has shown tremendous progress in the last few years. This trend is observed due to the flourishing growth of personal health devices, which can be easily worn or used with a smartphone or tablet. Mobile Health refers to the use of mobile communications, such as personal digital assistant (PDAs), laptops, and mobile phones among others, for health services and information.

The mHealth services dominated the market in 2014 and are expected to grow over $55.63 billion by the end of the forecast period due to the increasing usage of mHealth solutions by healthcare providers and pharmaceutical companies along with end users (patients). However, device segment is expected to grow in near future with a high CAGR of 38.02%, from 2015 to 2022, due to increasing integration of mHealth devices with smart phones and weareables, and also, increasing opportunities of connected health solutions are predicted to promote the growth of this market through the forecast period.

image1

Key question answered in the report:

  • What are the major market drivers, challenges and opportunities of the mHealth market and their use cases?
  • Which factors will be driving the market through the forecast period?
  • What factors are currently challenging the mHealth industry?
  • What are the use cases and key platforms to deliver the services of each application?
  • What are the key developmental strategies in different applications across all regions?
  • How will the key market players leverage on key developments such as Mergers and Acquisitions, Partnerships, and Product Launch among others?
  • Which compliances and certifications are necessary to make a product acceptable?
  • Which geographical region will lead the global mHealth market by the end of the forecast period?
  • Who are the key players in the mHealth market?

Table of Contents

1 REPORT SCOPE

  • 1.1 SCOPE OF THE STUDY
    • 1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE
    • 1.1.2 BIS RESEARCH METHODOLOGY
    • 1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL MARKET STUDY
      • 1.1.3.1 Geographical Analysis
      • 1.1.3.2 Demand Side & Supply Side Analysis
      • 1.1.3.3 Data Synthesis & Bridging
    • 1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY
    • 1.1.5 KEY DATA POINT SOURCES
      • 1.1.5.1 Data Points taken from Secondary Sources
      • 1.1.5.2 Data Points taken from Primary Sources
    • 1.1.6 REPORT DESCRIPTION

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

  • 3.1 INTRODUCTION
  • 3.2 MARKET DYNAMICS
    • 3.2.1 MARKET DRIVERS
      • 3.2.1.1 Patients Involvement in personal healthcare
      • 3.2.1.2 Proliferation of Smartphones and wearable devices into healthcare
      • 3.2.1.3 Integration of wireless technologies with portable healthcare devices
      • 3.2.1.4 Introduction of connected healthcare solutions in the mHealth market
      • 3.2.1.5 Benefits of Cost effectiveness and Patients'Convenience
      • 3.2.1.6 Increase in Lifestyle Disease
    • 3.2.2 MARKET CHALLENGES
      • 3.2.2.1 Low rate of literacy and language barriers in low-and middle-income countries (LMICs)
      • 3.2.2.2 Invasion of Privacy
        • 3.2.2.2.1 Security Breach Cases
        • 3.2.2.2.2 Potential risk of Hardware or Software failure
        • 3.2.2.2.3 Stringent Regulations and Standards
        • 3.2.2.2.4 Lack of Awareness about the possible applications of mHealth
    • 3.2.3 MARKET OPPORTUNITIES
      • 3.2.3.1 Partnership: An entry mode
      • 3.2.3.2 Introduction of mHealth in developing economies

4 INDUSTRY DYNAMICS

  • 4.1 MHEALTH MARKET TIMELINE
  • 4.2 VALUE CHAIN OF THE MHEALTH MARKET
    • 4.2.1.1 Device Manufacturers
      • 4.2.1.2 App Developers
      • 4.2.1.3 Network providers/ Mobile operators
      • 4.2.1.4 Healthcare providers and Pharmaceuticals
      • 4.2.1.5 Patients
      • 4.2.1.6 Consortiums, Certification, Regulations, & Standards
        • 4.2.1.6.1 Introduction
        • 4.2.1.6.2 Consortiums
        • 4.2.1.6.3 Alliance/Associations
        • 4.2.1.6.4 Regulatory Bodies
      • 4.2.1.7 Food and Drug Administration (FDA)
      • 4.2.1.8 Medical Device Regulation Act
      • 4.2.1.9 Medical Mobile Application(MMA)
    • 4.2.2 CERTIFICATION
    • 4.2.3 MHEALTH DEVICE: PORTER'S FIVE FORCE ANALYSIS
    • 4.2.4 BARGAINING POWER OF BUYER
    • 4.2.5 BARGAINING POWER OF SUPPLIER
    • 4.2.6 THREAT FROM SUBSTITUTE
    • 4.2.7 THREAT FROM A NEW ENTRANT
    • 4.2.8 INTENSITY OF COMPETITIVE RIVALRY

5 GLOBAL MHEALTH MARKET ECOSYSTEM

  • 5.1 INTRODUCTION
    • 5.1.1 MHEALTH DEVICES
    • 5.1.2 MEDICAL DEVICES
      • 5.1.2.1 SMBG monitor
        • 5.1.2.1.1 SMBG Device Types& Uses
        • 5.1.2.1.2 Diseases Managed by SMBG Device
        • 5.1.2.1.3 Key players
      • 5.1.2.2 Blood Pressure (BP) Monitor
        • 5.1.2.2.1 BP Monitor Device Types & Uses
        • 5.1.2.2.2 Diseases Managed by BP Monitor Device
        • 5.1.2.2.3 Key players
        • 5.1.2.2.4 Pulse Oximeter
        • 5.1.2.2.5 Pulse Oximeter : Types & Uses
        • 5.1.2.2.6 Diseases Managed by Pulse Oximeter Device
        • 5.1.2.2.7 Key players
      • 5.1.2.3 Cardiac Monitors
        • 5.1.2.3.1 Diseases Managed by Cardiac Monitors
        • 5.1.2.3.2 Disease Management Devices Types
        • 5.1.2.3.3 Cardiac Monitor Uses
      • 5.1.2.4 Key players
      • 5.1.2.5 Other medical devices
        • 5.1.2.5.1 Health and Fitness Devices
        • 5.1.2.5.2 Hand Worn Products
          • 5.1.2.5.2.1 Smart Watch
          • 5.1.2.5.2.2 Wrist Wear
        • 5.1.2.5.3 Key players
        • 5.1.2.5.4 Head Worn Products
          • 5.1.2.5.4.1 AR/VR HMD/HUD
          • 5.1.2.5.4.2 Others
          • 5.1.2.5.4.3 Body worn products
          • 5.1.2.5.4.4 Smart Textile
          • 5.1.2.5.4.5 Wearable Patch
          • 5.1.2.5.4.6 Others
        • 5.1.2.5.5 Non-Clinical applications
        • 5.1.2.5.6 Clinical Application
      • 5.1.2.6 Others Devices
        • 5.1.2.6.1 Mobile telemedicine/tele-care devices
        • 5.1.2.6.2 Home care devices
          • 5.1.2.6.2.1 Vessyl
          • 5.1.2.6.2.2 TAO
          • 5.1.2.6.2.3 CubeSensors
          • 5.1.2.6.2.4 Kolibree
          • 5.1.2.6.2.5 TellSpec
          • 5.1.2.6.2.6 Kinsa
          • 5.1.2.6.2.7 Beddit
          • 5.1.2.6.2.8 Wello iPhone Case
        • 5.1.2.6.3 Key Participants
      • 5.1.2.7 mHealth Services
    • 5.1.3 MOBILE HEALTH APPS AND CONTENT SOLUTION
      • 5.1.3.1 Software
      • 5.1.3.2 Big data
      • 5.1.3.3 Key Market Trends, Developments and Participants
        • 5.1.3.3.1 Market Trends and Market Developments
        • 5.1.3.3.2 Key Participants
    • 5.1.4 NETWORK AND SERVICES/ MOBILE OPERATORS
      • 5.1.4.1 Benefits of network & Services
      • 5.1.4.2 Key Market Trends, Developments and Participants
        • 5.1.4.2.1 Market Trends and Market Developments
        • 5.1.4.2.2 Key Participants
    • 5.1.5 HEALTHCARE AND PHARMACEUTICALS
      • 5.1.5.1 Healthcare providers
      • 5.1.5.2 Pharmaceuticals
        • 5.1.5.2.1 Key Market Trends, Developments and Participants
          • 5.1.5.2.1.1 Market Trends and Market Developments
          • 5.1.5.2.1.2 Key Participants

6 GLOBAL MHEALTH MARKET - THERAPEUTICS

  • 6.1 INTRODUCTION
    • 6.1.1 GLOBAL MARKET STATISTICS
      • 6.1.1.1 Cardiovascular Diseases
    • 6.1.2 DEVICES
    • 6.1.3 APPS
    • 6.1.4 KEY PLAYERS
  • 6.2 DIABETES
    • 6.2.1 DEVICES
    • 6.2.2 APPS
    • 6.2.3 KEY PLAYERS
  • 6.3 RESPIRATORY
    • 6.3.1 DEVICES
    • 6.3.2 APPS
    • 6.3.3 KEY PLAYERS
  • 6.4 MENTAL AND NEUROLOGICAL DISORDERS
    • 6.4.1 DEVICES
    • 6.4.2 APPS
    • 6.4.3 KEY PLAYERS
  • 6.5 FITNESS & LIFESTYLE THERAPEUTICS
    • 6.5.1 DEVICES
    • 6.5.2 APPS
    • 6.5.3 KEY PLAYERS
    • 6.6 OTHERS

7 GLOBAL MHEALTHMARKET - APPLICATION/SOLUTION TYPE

  • 7.1 INTRODUCTION
    • 7.1.1 MONITORING APPLICATIONS
      • 7.1.1.1 Key Participants
    • 7.1.2 DIAGNOSIS & TREATMENT
      • 7.1.2.1 Key Participants
    • 7.1.3 EDUCATION AND AWARENESS
      • 7.1.3.1 Key Participants
    • 7.1.4 HEALTHCARE MANAGEMENT
    • 7.1.5 WELLNESS & PREVENTION
    • 7.1.6 OTHERS/ OTHER SERVICES AND APPLICATIONS MARKET
    • 7.1.7 REMOTE DATA COLLECTION
      • 7.1.7.1 Key Market Developments

8 GLOBAL MHEALTH MARKET-GEOGRAPHY

  • 8.1 INTRODUCTION
    • 8.1.1 MARKET STATISTICS
    • 8.1.2 THE AMERICAS
    • 8.1.3 NORTH AMERICA
      • 8.1.3.1 The U.S.
        • 8.1.3.1.1 Key Market trends, Developments and Participants
          • 8.1.3.1.1.1 Key Market Trends and Developments
          • 8.1.3.1.1.2 Key Participants
      • 8.1.3.2 Canada
        • 8.1.3.2.1 Key Market Trend
        • 8.1.3.2.2 Key players
      • 8.1.3.3 South America
        • 8.1.3.3.1 Constraints
        • 8.1.3.3.2 Key Market Trends, Developments and Participants
          • 8.1.3.3.2.1 Market Trends and Market Developments
          • 8.1.3.3.2.2 Key Participants
    • 8.1.4 ASIA-PACIFIC (APAC)
      • 8.1.4.1 Key Drivers in APAC
        • 8.1.4.1.1 Key Market Trends, Developments and Participants
          • 8.1.4.1.1.1 Market Trends & Development
          • 8.1.4.1.1.2 Key Participants
      • 8.1.4.2 CHINA
      • 8.1.4.3 JAPAN
      • 8.1.4.4 AUSTRALIA
      • 8.1.4.5 INDIA
    • 8.1.5 EUROPE
      • 8.1.5.1 Key Market Trends, Developments and Participants
      • 8.1.5.2 The U.K.
      • 8.1.5.3 Germany
      • 8.1.5.4 Key Participants
    • 8.1.6 REST OF THE WORLD (ROW)
      • 8.1.6.1 Africa
        • 8.1.6.1.1 Key Market Trends, Developments and Participants
          • 8.1.6.1.1.1 Market Trends and Market Developments
        • 8.1.6.1.2 Key Participants
    • 8.1.7 MIDDLE EAST
      • 8.1.7.1 Key Market Trends, Developments and Participants
        • 8.1.7.1.1 Market Trends and Market Developments
        • 8.1.7.1.2 Key Participants

9 KEY MARKET DEVELOPMENT AND STRATEGIES

  • 9.1 INTRODUCTION
    • 9.1.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 9.1.2 MERGERS & ACQUISITIONS
    • 9.1.3 PRODUCT DEVELOPMENT AND LAUNCH
    • 9.1.4 BUSINESS EXPANSION/CONTRACTS
    • 9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS
    • 9.1.6 OTHERS (EVENTS & RECOGNITIONS)

10 COMPANY PROFILES

  • 10.1 AGAMATRIX, INC.
    • 10.1.1 OVERVIEW
    • 10.1.2 FINANCIALS
    • 10.1.3 KEY DEVELOPMENTS
  • 10.2 ALIVECOR, INC.
    • 10.2.1 OVERVIEW
    • 10.2.2 FINANCIALS
    • 10.2.3 KEY DEVELOPMENTS
  • 10.3 APPLE, INC.
    • 10.3.1 OVERVIEW
    • 10.3.2 FINANCIALS
      • 10.3.2.1 Overall Financials
      • 10.3.2.2 Financials By Segment
      • 10.3.2.3 Financials By Region
      • 10.3.2.4 Financial Summary
    • 10.3.3 KEY DEVELOPMENT
  • 10.4 ATHENAHEALTH INC.
    • 10.4.1 OVERVIEW
    • 10.4.2 FINANCIALS
      • 10.4.2.1 Overall Financials
      • 10.4.2.2 Financial by Segments
      • 10.4.2.3 Financial Summary
    • 10.4.3 KEY DEVELOPMENT
  • 10.5 AT&T, INC.
    • 10.5.1 OVERVIEW
    • 10.5.2 FINANCIALS
      • 10.5.2.1 Overall Financials
      • 10.5.2.2 Financials By Segment
      • 10.5.2.3 Financial Summary
    • 10.5.3 KEY DEVELOPMENTS
  • 10.6 BIOTELEMETRY, INC. (CARDIONET)
    • 10.6.1 OVERVIEW
    • 10.6.2 FINANCIALS
      • 10.6.2.1 Overall Financials
      • 10.6.2.2 Financials by Segment
      • 10.6.2.3 Financial Summary
    • 10.6.3 KEY DEVELOPMENTS
  • 10.7 GE HEALTHCARE
    • 10.7.1 OVERVIEW
    • 10.7.2 FINANCIALS
      • 10.7.2.1 Overall Financials
      • 10.7.2.2 Financials by Segment
      • 10.7.2.3 Financial Summary
    • 10.7.3 KEY DEVELOPMENTS
  • 10.8 GOOGLE INC.
    • 10.8.1 OVERVIEW
    • 10.8.2 FINANCIALS
      • 10.8.2.1 Financial Summary
    • 10.8.3 KEY DEVELOPMENTS
  • 10.9 JAWBONE, INC.
    • 10.9.1 OVERVIEW
    • 10.9.2 FINANCIALS
    • 10.9.3 KEY DEVELOPMENTS
  • 10.10 JOHNSON & JOHNSON
    • 10.10.1 OVERVIEW
    • 10.10.2 FINANCIALS
      • 10.10.2.1 Overall Financials
      • 10.10.2.2 Net Revenue By Segment
      • 10.10.2.3 Net revenue by Region
    • 10.10.3 KEY DEVELOPMENTS
  • 10.11 LABORATORY CORPORATION OF AMERICA HOLDINGS
    • 10.11.1 OVERVIEW
    • 10.11.2 FINANCIALS
      • 10.11.2.1 Overall Financials
      • 10.11.2.2 Financials by Segment
      • 10.11.2.3 Financial Summary
    • 10.11.3 KEY DEVELOPMENTS
  • 10.12 MEDTRONIC PLC
    • 10.12.1 OVERVIEW
    • 10.12.2 FINANCIALS
      • 10.12.2.1 Overall Financials
      • 10.12.2.2 Financial Summary
    • 10.12.3 KEY DEVELOPMENTS
  • 10.13 NIKE INC.
    • 10.13.1 OVERVIEW
    • 10.13.2 FINANCIALS
      • 10.13.2.1 Overall Financials
      • 10.13.2.2 Financials by Segments
      • 10.13.2.3 Financial Summary
    • 10.13.3 KEY DEVELOPMENTS
  • 10.14 PFIZER
    • 10.14.1 OVERVIEW
    • 10.14.2 FINANCIALS
      • 10.14.2.1 Overall Financials
      • 10.14.2.2 Financials by Segment
      • 10.14.2.3 Financials By Region
      • 10.14.2.4 FINANCIAL SUMMARY
    • 10.14.3 KEY DEVELOPMENTS
  • 10.15 PHILIPS HEALTHCARE
    • 10.15.1 OVERVIEW
    • 10.15.2 FINANCIALS
      • 10.15.2.1 Overall Financials
      • 10.15.2.2 Financials By Region
      • 10.15.2.3 Financials By Segment
      • 10.15.2.4 Financial Summary
    • 10.15.3 KEY DEVELOPMENTS
  • 10.16 QUALCOMM, INC.
    • 10.16.1 OVERVIEW
    • 10.16.2 FINANCIALS
      • 10.16.2.1 Overall Financials
      • 10.16.2.2 Financials By Segment
      • 10.16.2.3 Financials By Region
      • 10.16.2.4 Financial Summary
    • 10.16.3 KEY DEVELOPMENTS
  • 10.17 QUEST DIAGNOSTICS INC.
    • 10.17.1 OVERVIEW
    • 10.17.2 FINANCIALS
      • 10.17.2.1 Overall Financials
      • 10.17.2.2 Financials by Segment
      • 10.17.2.3 Financial Summary
    • 10.17.3 KEY DEVELOPMENTS
  • 10.18 ROCHE HOLDING AG-BR
    • 10.18.1 OVERVIEW
    • 10.18.2 FINANCIALS
      • 10.18.2.1 Overall Financials
      • 10.18.2.2 Financials by Segment
      • 10.18.2.3 Financial Summary
    • 10.18.3 KEY DEVELOPMENTS
  • 10.19 SAMSUNG ELECTRONICS CO. LTD.
    • 10.19.1 OVERVIEW
    • 10.19.2 FINANCIALS
      • 10.19.2.1 Overall financials
      • 10.19.2.2 Financial Summary
    • 10.19.3 KEY DEVELOPMENTS
  • 10.20 SANOFI PHARMA
    • 10.20.1 OVERVIEW
    • 10.20.2 FINANCIALS
      • 10.20.2.1 Overall Financials
    • 10.20.3 FINANCIALS BY SEGMENT
    • 10.20.4 FINANCIAL SUMMARY
    • 10.20.5 KEY DEVELOPMENTS
  • 10.21 WITHINGS SAS
    • 10.21.1 OVERVIEW
    • 10.21.2 FINANCIALS
    • 10.21.3 KEY DEVELOPMENTS

List of Tables

  • TABLE 1 LEADING COMPANIES IN THE MHEALTH MARKET
  • TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2011-2015)
  • TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS
  • TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM
  • TABLE 5 CONSORTIUMS IN MHEALTH MARKET
  • TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET
  • TABLE 7 REGULATORY BODIES IN MHEALTH MARKET
  • TABLE 8 MHEALTH MARKET CERTIFICATIONS
  • TABLE 9 FACTORS IMPACTING THE BUYER'S BARGAINING POWER
  • TABLE 10 FACTORS IMPACTING THE SUPPLIER'S BARGAINING POWER
  • TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE
  • TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT
  • TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION
  • TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
  • TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2014-2022 ($MILLION)
  • TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)
  • TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2014-2022 ($MILLION)
  • TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)
  • TABLE 19 KEY DEVELOPMENTS
  • TABLE 20 NETWORK & SERVICES: KEY DEVELOPMENTS
  • TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT
  • TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 25 TYPE OF APP
  • TABLE 26 KEY DEVELOPMENTS
  • TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 29 KEY DEVELOPMENTS
  • TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 34 FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 35 FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
  • TABLE 40 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 41 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 42 REMOTE MONITORING IN GEOGRAPHIES
  • TABLE 43 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
  • TABLE 44 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 45 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES
  • TABLE 47 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
  • TABLE 48 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 49 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 50 EDUCATION & WELLNESS IN GEOGRAPHIES
  • TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
  • TABLE 52 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 53 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES
  • TABLE 55 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
  • TABLE 56 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 57 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 58 WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES
  • TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
  • TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 62 MHEALTH: KEY DEVELOPMENTS (2011- 2015)
  • TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION)
  • TABLE 65 THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 66 THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 67 THE U.S.: KEY DEVELOPMENTS
  • TABLE 68 SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2011-2015)
  • TABLE 69 APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 70 APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 71 KEY DEVELOPMENTS IN APAC
  • TABLE 72 EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 73 EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 74 EUROPE: MHEALTH MARKET DEVELOPMENT
  • TABLE 75 ROW: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION)
  • TABLE 76 ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • TABLE 77 ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 78 AFRICA: MHEALTH MARKET DEVELOPMENTS(2011-2014)
  • TABLE 79 MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2014-2011)

List of Figures

  • FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA
  • FIGURE 2 BIS RESEARCH METHODOLOGY
  • FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET
  • FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY
  • FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2014-2022 ($MILLION)
  • FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2014-2022 ($MILLION)
  • FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2022 ($MILLION)
  • FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • FIGURE 9 MARKET DRIVERS AND CHALLENGES
  • FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS
  • FIGURE 11 BENEFITS OF MHEALTH TO PATIENTS
  • FIGURE 12 EXAMPLES OF EXISTING MHEALTH INNOVATIONS
  • FIGURE 13 MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS
  • FIGURE 14 MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS
  • FIGURE 15 VALUE CHAIN
  • FIGURE 16 ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS
  • FIGURE 17 CLASSIFICATION OF MEDICAL DEVICES
  • FIGURE 18 MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS
  • FIGURE 19 MHEALTH ECOSYSTEM
  • FIGURE 20 TYPE OF MHEALTH DEVICES
  • FIGURE 21 SMBD DEVICE USES
  • FIGURE 22 USES OF BP MONITORING DEVICE
  • FIGURE 23 PULSE OXIMETER USES
  • FIGURE 24 WEARABLE DEVICE COMPONENTS
  • FIGURE 25 TYPE OF WEARABLE ELECTRONICS DEVICES
  • FIGURE 26 HAND WORN MHEALTH DEVICES
  • FIGURE 27 APPLE WATCH FIGURE
  • FIGURE 28 LEADING FITNESS TRACKING WRIST BANDS
  • FIGURE 29 GOOGLE'S CONTACT LENS
  • FIGURE 30 HEAD WORN DEVICES
  • FIGURE 31 ELECTRONIC FINGERTIP
  • FIGURE 32 COMPONENTS OF BIOSTAMP
  • FIGURE 33 MYO ARMBAND BY THALMIC LABS
  • FIGURE 34 NON-CLINICAL BENEFITS
  • FIGURE 35 WEARABLE MEDICAL DEVICES
  • FIGURE 36 FITNESS TRACKING DEVICES
  • FIGURE 37 TYPES OF MHEALTH SERVICES
  • FIGURE 38 TYPES OF APPS
  • FIGURE 39 BENEFITS OF BIG DATA
  • FIGURE 40 BENEFITS OF NETWORK & SERVICES
  • FIGURE 41 ROLES OF MOBILE OPERATORS
  • FIGURE 42 ROLE OF HEALTHCARE PROVIDERS
  • FIGURE 43 MHEALTH: MARKET BY THERAPEUTICS
  • FIGURE 44 BENEFITS OF MHEALTH IN CVDS
  • FIGURE 45 BENEFITS OF MHEALTH
  • FIGURE 46 BENEFITS OF MHEALTH
  • FIGURE 47 BENEFITS OF MHEALTH
  • FIGURE 48 BENEFITS OF MHEALTH
  • FIGURE 49 TYPES OF MHEALTH APPLICATION
  • FIGURE 50 ADVANTAGES OF REMOTE MONITORING
  • FIGURE 51 DIAGNOSIS AND TREATMENT SERVICES
  • FIGURE 52 EDUCATION & AWARENESS SERVICES
  • FIGURE 53 MHEALTH HEALTHCARE MANAGEMENT
  • FIGURE 54 GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY
  • FIGURE 55 APAC: MARKET DRIVERS
  • FIGURE 56 MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2015)
  • FIGURE 57 MHEALTH: MERGERS & ACQUISITIONS(2015)
  • FIGURE 58 MHEALTH: KEY PRODUCT LAUNCH & DEVELOPMENTS (2015)
  • FIGURE 59 MHEALTH: KEY BUSINESS EXPANSIONS & CONTRACTS (2015)
  • FIGURE 60 MHEALTH: KEY PATENTS/APPROVALS( 2015)
  • FIGURE 61 APPLE INC. OVERALL FINANCIALS ($BILLION), 2012-2014
  • FIGURE 62 APPLE INC.: NET REVENUE, BY SEGMENT, 2012-2014
  • FIGURE 63 APPLE INC.: NET REVENUE, BY REGION, 2012-2014
  • FIGURE 64 ATHENAHEALTH: OVERALL FINANCIALS, 2012-2014 ($MILLION)
  • FIGURE 65 ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION)
  • FIGURE 66 AT&T INC.: OVERALL FINANCIALS ($BILLION), 2012-2014
  • FIGURE 67 AT&T INC.: NET REVENUE BY SEGMENT, 2012-2014
  • FIGURE 68 BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2012-2014
  • FIGURE 69 BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014
  • FIGURE 70 GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2012-2014
  • FIGURE 71 GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014
  • FIGURE 72 GE HEALTHCARE SEGMENT, 2014
  • FIGURE 73 GOOGLE: OVERALL FINANCIALS, 2012 - 2014 ($BILLION)
  • FIGURE 74 J&J: OVERALL FINANCIALS, 2012 - 2014 ($ BILLION)
  • FIGURE 75 LABCORP OVERALL FINANCIALS ($MILLION), 2012-2014
  • FIGURE 76 NET REVENUE BY SEGMENTS, 2012-2014
  • FIGURE 77 NIKE: OVERALL FINANCIALS 2012 - 2014 ($BILLION)
  • FIGURE 78 NIKE: REVENUE BY REGION (2012-2013)
  • FIGURE 79 PFIZER: OVERALL FINANCIALS, 2012-2014 ($BILLION)
  • FIGURE 80 PFIZER: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION)
  • FIGURE 81 PFIZER: FINANCIALS BY REGION, 2012-2013 ($BILLION)
  • FIGURE 82 PHILIPS: OVERALL FINANCIALS, 2012-2014 ($MILLION)
  • FIGURE 83 PHILIPS: FINANCIALS BY REGION, 2012-2014 ($MILLION)
  • FIGURE 84 PHILIPS: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION)
  • FIGURE 85 QUALCOMM INC.: OVERALL FINANCIALS, 2012-2014 ($BILLION)
  • FIGURE 86 QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION)
  • FIGURE 87 QUALCOMM INC.: NET REVENUE, BY REGION, 2012-2014 ($MILLION)
  • FIGURE 88 QUEST: OVERALL FINANCIALS, 2012-2014 ($MILLION)
  • FIGURE 89 QUEST: NET REVENUE BY SEGMENTS, 2013-2014 ($MILLION)
  • FIGURE 90 ROCHE: OVERALL FINANCIALS, 2012-2014 ($BILLION)
  • FIGURE 91 ROCHE: NET REVENUE, BY SEGMENTS, 2012-2014 ($BILLION)
  • FIGURE 92 SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION), 2012-2014
  • FIGURE 93 SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2012-2014
  • FIGURE 94 SANOFI PHARMA: NET REVENUE BY SEGMENT, 2012-2014
Back to Top